BridgeMD
New treatment option for Fractures, Closed
Official title Regional Blocks for Lateral Condyle Fractures
ClinicalTrials.gov ID: NCT03796572
What this study is testing
What is Ropivacaine?
Ropivacaine is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for fractures, closed.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to investigate the post-operative pain control in pediatric patients with closed lateral condyle fractures who undergo open reduction and percutaneous pinning. Patients will be randomized into one of two groups.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 12. Healthy volunteers may be eligible.
You may be able to join if
- Isolated lateral condyle humerus fracture
- Closed lateral condyle humerus fracture
- Weiss classification type II and III (\>2mm displacement) lateral condyle fractures
- Fractures treated with open reduction percutaneous pinning requiring fixation
You likely can't join if
- Open fractures
- Fractures with concomitant vascular or neurologic deficit
- Pathologic fractures
- Those presenting with concomitant injuries
- Swelling requiring post-operative hospitalization for monitoring
- Any known history of allergies to ropivacaine or oxycodone
See the full eligibility criteria
- Isolated lateral condyle humerus fracture
- Closed lateral condyle humerus fracture
- Weiss classification type II and III (\>2mm displacement) lateral condyle fractures
- Fractures treated with open reduction percutaneous pinning requiring fixation
- Open fractures
- Fractures with concomitant vascular or neurologic deficit
- Pathologic fractures
- Those presenting with concomitant injuries
- Swelling requiring post-operative hospitalization for monitoring
- Any known history of allergies to ropivacaine or oxycodone
- Patients with developmental delay that would preclude participation in the visual analog Faces Pain Scale-Revised
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 12 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.